The Antibiotic Development Pipeline for Multidrug-Resistant Gram-Negative Bacilli: Current and Future Landscapes

被引：14
|
作者：
Talbot, George H. [1 ]
机构：
[1] Talbot Advisors LLC, Wayne, PA USA
来源：
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY | 2010年 / 31卷
关键词：
DRUGS;
D O I：
10.1086/655988
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
Development of antibiotics to treat infections caused by multidrug-resistant gram-negative bacilli has lagged significantly behind development of antibiotics to treat infections with gram-positive pathogens. Although a few promising drugs have entered early clinical development, more must be done to preserve the utility of currently available antibiotics and to ensure a pipeline of efficacious, safe antibacterials.
引用
收藏
页码：S55 / S58
页数：4
相关论文
共 50 条
  • [21] Potential Tamoxifen Repurposing to Combat Infections by Multidrug-Resistant Gram-Negative Bacilli
    Miro-Canturri, Andrea
    Ayerbe-Algaba, Rafael
    del Toro, Raquel
    Mejias, Manuel Enrique-Jimenez
    Pachon, Jeronimo
    Smani, Younes
    PHARMACEUTICALS, 2021, 14 (06)
  • [22] The clinical impact of multidrug-resistant gram-negative bacilli in the management of septic shock
    Pop-Vicas, Aurora
    Opal, Steven M.
    VIRULENCE, 2014, 5 (01) : 206 - 212
  • [23] Current and future treatment options for infections caused by multidrug-resistant Gram-negative pathogens
    Poulakou, Garyphallia
    Bassetti, Matteo
    Righi, Elda
    Dimopoulos, George
    FUTURE MICROBIOLOGY, 2014, 9 (09) : 1053 - 1069
  • [24] Cefiderocol, a new antibiotic against multidrug-resistant Gram-negative bacteria
    Tiago Silva, Jose
    Lopez-Medrano, Francisco
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2021, 34 : 41 - 43
  • [25] Cefiderocol: a promising antibiotic against multidrug-resistant Gram-negative bacteria
    Jean, Shio-Shin
    Hsueh, Shun-Chung
    Lee, Wen-Sen
    Hsueh, Po-Ren
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2019, 17 (05) : 307 - 309
  • [26] Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes
    Gudiol, C.
    Tubau, F.
    Calatayud, L.
    Garcia-Vidal, C.
    Cisnal, M.
    Sanchez-Ortega, I.
    Duarte, R.
    Calvo, M.
    Carratala, J.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (03) : 657 - 663
  • [27] Investigation of antibiotic resistance in the genomic era of multidrug-resistant Gram-negative bacilli, especially Enterobacteriaceae, Pseudomonas and Acinetobacter
    Diene, Seydina M.
    Rolain, Jean-Marc
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2013, 11 (03) : 277 - 296
  • [28] The Relationship between Extensively Drug-Resistant Tuberculosis and Multidrug-Resistant Gram-Negative Bacilli
    Zhao, Jiang-nan
    Zhang, Xian-xin
    He, Xiao-chun
    Yang, Guo-ru
    Zhang, Xiao-qi
    Li, Huai-chen
    PLOS ONE, 2015, 10 (07):
  • [29] Antibiotics for multidrug-resistant gram-negative bacteria
    Kang, Cheol-In
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2022, 65 (08): : 490 - 497
  • [30] Multidrug-resistant Gram-negative bacterial infections
    Macesic, Nenad
    Uhlemann, Anne-Catrin
    Peleg, Anton Y.
    LANCET, 2025, 405 (10474): : 257 - 272
12345